Annex

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ivermectin is replaced by the following:

Pharmacologically active substance	Marker residue	Animal species	MRL	Target tissues	Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic classification
‘Ivermectin	22, 23-Dihydro-avermectin B 1a	All mammalian food producing species	30 μg/kg 100 μg/kg 100 μg/kg 30 μg/kg	Muscle Fat Liver Kidney	For porcine species the fat MRL relates to “skin and fat in natural proportions” Not for use in animals from which milk is produced for human consumption	Antiparasitic agents/Agents acting against endo and ectoparasites’